This resolution matters because it uses the platform of the U.S. Senate to shine a spotlight on Amyotrophic Lateral Sclerosis, a devastating disease with no cure. By designating an awareness month, it helps educate the public about what ALS is, its impact on individuals and families, and the urgent need for research and better treatments. This increased visibility can encourage conversations, reduce stigma, and potentially lead to greater support for affected individuals and their caregivers.

If this resolution becomes law, it provides a national focus during May 2025 to discuss ALS, share patient stories, and highlight ongoing scientific efforts. If it doesn't pass, there wouldn't be this official, high-profile designation, which could mean less public attention and potentially fewer opportunities for fundraising or community engagement focused on ALS during that specific month.